Craig Pendergrass
Family Medicine · Neosho, MONPI 1700835469
Payments from drug & device makers
Across 878 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Amgen$1K
- Novo Nordisk$1K
- AbbVie$1K
- Pfizer$1K
- Johnson & Johnson$777
- plus $5K from 35 others
What the payments were for
- Food & beverage$12,271100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$12,271 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 125 | $102,798 |
| IngrezzaValbenazine Tosylate | 12 | $102,545 |
| FarxigaDapagliflozin Propanediol | 148 | $100,194 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 82 | $69,791 |
| OzempicSemaglutide | 78 | $69,441 |
| XeljanzTofacitinib Citrate | 11 | $65,189 |
| EliquisApixaban | 74 | $52,629 |
| EntrestoSacubitril/Valsartan | 37 | $29,898 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 38 | $24,040 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 89 | $18,910 |
| Tresiba Flextouch U-200Insulin Degludec | 29 | $17,452 |
| JardianceEmpagliflozin | 27 | $16,599 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $16,412 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 47 | $13,650 |
| SymbicortBudesonide/Formoterol Fumarate | 49 | $12,183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,749 | $128,789221 claims |
| PfizerXeljanz, Eliquis, Premarin | $1,068 | $120,45297 claims |
| Johnson & JohnsonXarelto, Invokana | $777 | $111,971139 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $81 | $102,54512 claims |
| Novo NordiskOzempic | $1,306 | $69,44178 claims |
| GSKShingrix, Arexvy, Anoro Ellipta, Breo Ellipta | $373 | $45,946166 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $428 | $32,56359 claims |
| NovartisEntresto | $260 | $29,89837 claims |
| Lilly USA, LLCMounjaro | $723 | $11,80311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Neosho
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.